Clinical Trials Logo

Gut Function clinical trials

View clinical trials related to Gut Function.

Filter by:
  • None
  • Page 1

NCT ID: NCT06444139 Not yet recruiting - Clinical trials for Occasional Constipation

Probiotic Intervention for Occasional Constipation

Start date: June 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to study the effect of probiotics on gut function in subjects with occasional constipation. The main question it aim to answer is if intake of probiotics will decrease the transit time. Participants will randomized to either consume probiotics or a placebo product.

NCT ID: NCT05155449 Recruiting - Gut Function Clinical Trials

Probiotic Intervention for Gut Function

Start date: February 8, 2023
Phase: N/A
Study type: Interventional

The effect of probiotics on gut function in healthy subjects.

NCT ID: NCT01750138 Recruiting - Gut Function Clinical Trials

SNE1725: Can Oral Glutamine Facilitate Early Return of Gut Function

Start date: June 2011
Phase: N/A
Study type: Interventional

The gastrointestinal tract has many functionsÍž it provides nutrition, produces hormones, performs a barrier function, maintains a stable gastrointestinal micro flora and plays an important role in the inflammatory process as it is the largest producer of cytokines (proteins associated with inflammation). This gut function is impaired after colorectal (bowel) surgery. There is evidence to suggest that impaired gut function is associated with increased complications. Hence if gut function is preserved, it should equate with better outcomes. As a result, there has been increasing interest in treatments called Gut Specific Nutrients (GSN), which specifically target gut function. Most notable of them is Glutamine, a conditionally essential amino acid and preferred fuel source for intestinal cells. Research has shown that glutamine promotes cell growth, increases clearance of harmful organisms from the blood, and reduces the surgical stress response. In other words, glutamine has a favourable influence on gut function. Recent studies from our unit using intravenous glutamine in critically ill patients have shown an early return of gut function, which in turn is associated with attenuation of the inflammatory response and improved outcomes. It is not known whether oral glutamine is associated with a similar outcome. A recent pilot study at our unit suggests an association between oral glutamine and early return of gut function. The aim of this research is to determine if giving oral glutamine results in an early return of gut function and whether this is associated with an attenuation of the systemic inflammatory response.